Related Experiment Video
Updated: Jun 16, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
The Impact of Human ABO Blood Groups on Thrombin Generation in Platelet-Poor Plasma
Background:
ABO blood group has been shown to influence plasma levels of von Willebrand factor (vWF) and factor VIII, contributing to individual variation in bleeding and thrombotic risk. Group O individuals typically present with lower vWF and factor VIII levels, associated with a higher bleeding tendency, whereas non-O groups tend to have elevated levels and an increased risk of thrombosis. However, it remains unclear whether ABO blood group also affects thrombin generation, a central parameter of coagulation potential.
Methods:
We performed a retrospective analysis of 1,423 patients who underwent routine thrombin generation testing using a calibrated automated thrombogram (CAT) in platelet-poor plasma. Thrombin generation parameters, including lag time, peak thrombin, and endogenous thrombin potential (ETP), were compared across ABO blood groups (O, A, B, AB). Statistical differences between groups were assessed using ANOVA and post hoc com-parisons, with a focus on potential clinical relevance.
Results:
Statistically significant differences were observed in lag time and ETP between ABO blood groups. Group O individuals showed a slightly prolonged lag time and reduced total thrombin compared to non-O groups. However, the absolute magnitude of these differences was small, with median variations well within assay variability. Peak thrombin did not differ meaningfully between groups.
Conclusions:
Although minor statistical differences in thrombin generation parameters were observed among ABO blood groups, their magnitude is unlikely to translate into clinically relevant effects. These findings suggest that the influence of ABO blood group on bleeding or thrombotic risk is not primarily mediated via changes in thrombin generation, but rather through vWF-related mechanisms such as platelet adhesion or clearance.
More Related Videos
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.